Merck’s prescription allergy medication Ragwitek is going before the FDA Allergenic Products Advisory Committee tomorrow, and the panel’s discussion documents indicate the under-the-tongue medication is not associated with serious safety concerns, reports Reuters.
An FDA approval would provide an alternative to injections doctors typically give for pollen and ragweed allergies.
